NJ Bio Partners with Charles River to Accelerate ADC Development
The biggest benefit of the Charles River and NJ Bio alliance is that clients can receive seamless complementary services to enhance outcomes and accelerate time-to-market for their ADCs.
Charles River Laboratories | 08/11/2024 | By Aishwarya
Charles River Laboratories, MatTek Receive Grant from FCRI to Advance Research Alternatives
Charles River Laboratories International, Inc. has announced a multidisciplinary program, funded through a USD 1.3 million grant from the Foundation for Chemistry Research & Initiatives (FCRI), in coordination with ACC LRI, to develop a New Approach Methodology (NAM) inhalation toxicology test to reduce reliance on traditional animal research methods.
Charles River Laboratories | 12/06/2024 | By Aishwarya | 237
US-based Charles River Laboratories opens plasmid production facility in UK
The 16,000-square-foot facility, located at the company’s Alderley Park site in Cheshire, England, was built to rapidly produce “phase-appropriate” plasmid DNA
Charles River Laboratories | 21/10/2022 | By Sudeep Soparkar | 360
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy